Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-07-08Clinical Trial Update: Triage of Reduced Exercise Tolerance in Frail Elderly [NA]
A completed clinical trial funded by UMC Utrecht investigating triage for reduced exercise tolerance in frail elderly patients with heart fa…
-
CLINICAL_TRIALS trial_result · 2014-07-08Clinical Trial Update: Ipratropium or Salbutamol Sulphate Alone or Combination Therapy Salbutamol and Ipratropium in Patients With COPD [Phase 4]
A Phase 4 COPD trial evaluating ipratropium bromide, salbutamol sulfate, or their combination has completed.
-
CLINICAL_TRIALS trial_result · 2014-07-08Clinical Trial Update: Pulmonary Embolism in Exacerbations of Chronic Obstructive Pulmonary Disease
This is a completed clinical trial examining pulmonary embolism in people with chronic obstructive pulmonary disease.
-
CLINICAL_TRIALS trial_result · 2014-07-03Clinical Trial Update: Implementation of Telemonitoring in Chronic Heart or Lung Failure [Phase 1]
Phase 1 clinical trial assessing telemonitoring for patients with chronic heart or lung failure has completed. Sponsored by Royal Brompton &…
-
CLINICAL_TRIALS trial_result · 2014-07-01Clinical Trial Update: BI 1744 CL With Respimat Once Daily Versus Twice Daily in COPD [Phase 2]
Phase 2 trial comparing once-daily versus twice-daily BI 1744 CL with the Respimat inhaler in chronic obstructive pulmonary disease; trial c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-07-01Clinical Trial Update: Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease [Phase 3]
Phase 3 study characterizing 24-hour spirometry profiles of inhaled BI 1744 CL versus inhaled formoterol (Foradil) in patients with chronic …
-
CLINICAL_TRIALS trial_result · 2014-06-30Clinical Trial Update: Single Dose Ranging Study of BI 1744 CL (Olodaterol) in Chronic Obstructive Pulmonary Disease [Phase 2]
Phase 2 single-dose dose-ranging study of olodaterol (BI 1744 CL) in chronic obstructive pulmonary disease; the trial completed and results …
-
CLINICAL_TRIALS trial_result · 2014-06-30Clinical Trial Update: Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease [Phase 3]
Phase 3 trial comparing inhaled BI 1744 CL with inhaled tiotropium bromide in chronic obstructive pulmonary disease was completed, with resu…
-
CLINICAL_TRIALS trial_result · 2014-06-30Clinical Trial Update: A Randomized, Double-Blind, 4-way Crossover Study to Evaluate the Efficacy of of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease [Phase 3]
A Phase 3 randomized, double-blind, four-way crossover trial comparing inhaled BI 1744 CL with inhaled tiotropium bromide in chronic obstruc…
-
FDA approval · 2014-06-28FDA Approved: BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for budesonide and formoterol fumarate dihydrate (AstraZeneca) to expand its approved indications fo…
-
CLINICAL_TRIALS trial_result · 2014-06-27Clinical Trial Update: Ipratropium Bromide/Salbutamol Delivered by the Respimat® Inhaler Compared to Ipratropium Bromide Respimat®, COMBIVENT® Inhalation Aerosol and Placebo in Adults With Chronic Obstructive Pulmonary Disease [Phase 3]
A Phase 3 study evaluated ipratropium bromide/salbutamol delivered by the Respimat inhaler against ipratropium bromide Respimat, Combivent i…
-
CLINICAL_TRIALS trial_result · 2014-06-27Clinical Trial Update: Characterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease [Phase 3]
Phase 3 trial characterising 24-hour FEV1 time profiles for inhaled BI 1744 CL and inhaled Foradil in patients with chronic obstructive pulm…
-
CLINICAL_TRIALS trial_result · 2014-06-27Clinical Trial Update: Tiotropium in the Treatment of the Patients With Chronic Obstructive Pulmonary Disease
A completed clinical trial update evaluating tiotropium in the treatment of patients with Chronic Obstructive Pulmonary Disease.
-
CLINICAL_TRIALS trial_result · 2014-06-26Clinical Trial Update: Efficacy and Safety of Tiotropium Compared to Salmeterol and Placebo in Patients With Chronic Obstructive Bronchitis (COPD) [Phase 3]
This Phase 3 trial update reports on the efficacy and safety of tiotropium compared with salmeterol and placebo in patients with chronic obs…
-
CLINICAL_TRIALS research · 2014-06-26Clinical Trial Update: Patient-centred Integrated Palliative Care Pathways in Advanced Cancer and Chronic Disease
An update on a study evaluating patient-centered integrated palliative care pathways for people with advanced cancer and other chronic disea…
-
CLINICAL_TRIALS trial_result · 2014-06-24Clinical Trial Update: Efficacy and Safety of Ba679BR Powder Inhalation in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
The document reports the completion of a Phase 3 clinical trial evaluating the efficacy and safety of Ba679BR powder inhalation in patients …
-
CLINICAL_TRIALS trial_result · 2014-06-24Clinical Trial Update: 12-week Treatment With Inhaled Tiotropium (18 mcg Once Daily) on Lung Function and Static Lung Volumes in Stable, Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Patients. Correlation to Dyspnoea Scales [Phase 3]
A Phase 3 clinical trial evaluating 12 weeks of once-daily inhaled tiotropium 18 mcg in stable moderate-to-severe COPD assessed effects on l…
-
CLINICAL_TRIALS trial_result · 2014-06-24Clinical Trial Update: A 24-week Study to Evaluate the Efficacy and Safety of GSK573719/GW642444 125/25 mcg and 62.5/25mcg Inhalation Powder Compared With Placebo in Subjects With COPD [Phase 3]
A Phase 3 trial comparing two dosages of inhaled GSK573719/GW642444 versus placebo in COPD completed with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-06-24Clinical Trial Update: Evaluation of the Lung Deposition Rate and Distribution Pattern of Tiotropium Via HandiHalerTM in Healthy Subjects and Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
Phase 3 trial evaluating lung deposition rate and distribution of tiotropium delivered by HandiHaler in healthy subjects and COPD patients. …
-
CLINICAL_TRIALS trial_result · 2014-06-24Clinical Trial Update: Effect of Spiriva® on Health-related Quality of Life in Chronic Obstructive Pulmonary Disease (COPD) Patients Who Stopped Smoking During Treatment.
Completed trial evaluating the impact of tiotropium (Spiriva) on health-related quality of life in chronic obstructive pulmonary disease pat…
-
CLINICAL_TRIALS trial_result · 2014-06-24Clinical Trial Update: Effect of Tiotropium on Exercise Tolerance in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
Clinical trial update on a Phase 3 study evaluating tiotropium's effect on exercise tolerance in patients with chronic obstructive pulmonary…
-
CLINICAL_TRIALS trial_result · 2014-06-24Clinical Trial Update: Efficacy and Safety of Tiotropium and Atrovent in Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
A Phase 3 clinical trial evaluated the efficacy and safety of tiotropium and ipratropium (Atrovent) in subjects with chronic obstructive pul…
-
CLINICAL_TRIALS trial_result · 2014-06-24Clinical Trial Update: Multiple Dose Comparison of Tiotropium Inhalation Capsules, Salmeterol Inhalation Aerosol and Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
A Phase 3 clinical trial comparing tiotropium inhalation capsules, salmeterol inhalation aerosol, and placebo in patients with chronic obstr…
-
CLINICAL_TRIALS trial_result · 2014-06-24Clinical Trial Update: Spiriva® in Patients With Chronic Obstructive Pulmonary Disease (COPD)
This update notes that a clinical trial evaluating Spiriva (tiotropium) in chronic obstructive pulmonary disease has completed. The snippet …
-
CLINICAL_TRIALS trial_result · 2014-06-24Clinical Trial Update: Effect of Spiriva® 18 Microgram on Health-related Quality of Life and Physical Functioning in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Proven Hyperinflation
Clinical trial evaluating the effect of Spiriva (tiotropium) 18 mcg on health-related quality of life and physical functioning in COPD with …